Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed May 17, 2022
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2022-05-13$1.53/sh+4,233$6,476→ 4,233 total
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.